Building the biology-based future January 30, 2025 12:00 PM PST Drug discovery is a famously challenging endeavor, with a 96% failure rate, a $1B+ price tag to develop a single drug, and a 10+ year timeline from discovery to commercialization. What if we could invert those numbers? Turn a 96% failure rate into a 96% […]
January 14, 2025 9:00 AM PST Milpitas, California, January 2025 – Applied StemCell, Inc., a proven CRO/CDMO and gene editing technology developer, is pleased to welcome Todd Garland to our Board of Directors and Mike Yurkovich as Vice President of Sales. Todd Garland brings over 30 years of expertise in product management, sales, and commercial […]
October 01, 2024 10:00 AM PST MILPITAS, Calif. – Applied StemCell, Inc. is proud to announce the successful approval of its latest U.S. patent which covers HLA-F engineered universal donor cells, marking a significant advancement in cell transplantation therapy and the first step towards an allogeneic cell therapy development platform. This innovation not only […]
